Gene Company Ltd Company Profile

09:51 EDT 20th March 2018 | BioPortfolio

Genomic Solutions designs, develops, manufactures, markets and sells genomic and proteomic instrumentation, software, consumables and services. We are the only company supplying tools and expertise for genomics , proteomics and high-throughput screening.

Our instruments can be purchased individually or as part of fully integrated systems tailored to genomic, proteomic and drug discovery research requirements. Our customers use our integrated, automated systems to facilitate more rapid and less expensive drug discovery. Genomic Solutions products provide high quality research data and fast turnaround time.


Unit A, 8/F., Shell Industrial Building 12 Lee Chung Street
Chai Wan
Hong Kong


Phone: (+852) 2896 6283
Fax: (+852) 2515 9371

News Articles [1328 Associated News Articles listed on BioPortfolio]

Direct evidence of the GC-NSF(a) hypothesis on creation of an entirely new gene/protein

(Bentham Science Publishers) The hypothesis assumes that an entirely new gene is produced from the non-stop frame on the antisense strand of a GC-rich gene after gene duplication, followed by the accu...

Meet the Company that Mastered Upscaling Gene Therapy Vectors

Developing biopharmaceutical, and especially cell-based products, on an industrial scale, has long been a challenge in the life sciences industry. Cevec is a German company that has met this growing d...

Gene By Gene Selects BC Platforms to Enhance its World Leading Genomic Data Processing Services

Through its division, Family Tree DNA, Gene by Gene was the first company globally to develop DNA testing for ancestry and genealogical purposes as a Read more...

You’ve Heard All About CRISPR Gene Editing—Here’s How It Works

Gene editing is in the news a lot these days, but what is it exactly? Gene editing is the process of making precise and permanent changes to living things at the level of DNA, or more specifically, to...

American Gene Technologies: the first bio-safe gene delivery vector for human clinical therapeutic use

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with Jeff Galvin, Chief Executive Officer at American Gene Technologies, a genetic research firm focusing on gene therap...

Low-cost way to build gene sequences

A new method enables an average biochemistry laboratory to make its own gene sequences for only about $2 per gene, a process that previously would require its researchers to pay a commercial vendor $5...

Merck Brings Customers Closer to Gene Therapy Product Commercialization

- Company's Carlsbad, U.S., manufacturing facility passes FDA and EMA inspections - Underscores capabilities as commercial manufacturer of viral and gene therapy products - Highlights position as ...

Gene Therapy 2.0: New Startups Aim to Fine-Tune Gene Delivery and Control

This past month brought a major milestone for gene therapy, a cutting edge type of medicine meant to permanently alter a patient’s genes to treat disease. For the first time, a gene therapy is avail...

PubMed Articles [1742 Associated PubMed Articles listed on BioPortfolio]

Bacteria and fungi in day-old turkeys vary among companies, collection periods, and breeder flocks.

Microbial colonization of the intestinal tract of commercial poultry is highly variable, likely due to the fact that poults and chicks are hatched and raised without exposure to adult birds and their ...

Editorial: In Good Company.

Crimean Thornapple Depicted by Liebig's Extract of Meat Company.

What do company health insurance plans provide?

Company health insurance plans are a voluntary employer benefit and an increasingly important part of company pension and benefits systems. They enable employers to invest in the health of their emplo...

A Gene is known by the Company it Keeps: Enrichment of TNFAIP3 Gene Aberrations in Malt Lymphomas Expressing IGHV4-34 Antigen Receptors.

Associations between immunoglobulin (IG) receptors with distinctive immunogenetic features and particular gene mutations is a recurring theme in mature B cell lymphomas. Relevant observations have bee...

Clinical Trials [1770 Associated Clinical Trials listed on BioPortfolio]

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Candidate Gene Screening for Attention Deficit/Hyperactive Disorder (ADHD)

Source: Sample bank of Xijing Hospital and Children's Hospital Affiliated to Soochow University; Sample form: Whole blood; Estimated number of samples: 100 patients with ADHD and age, sex ...

Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study)

The metabolic syndrome is a highly prevalent disorder, which causes atherosclerotic cardiovascular disease and is closely associated with insulin resistance. The alteration of the secretio...

Genomic Structural Variation in Cancer Susceptibility

This study will look for new types of gene changes that may be related to cancer in some patients. Some gene changes (mutations) are passed on from parents to offspring (child). Other gene...

Companies [1904 Associated Companies listed on BioPortfolio]

Gene Expression Technologies

Gene Expression Technologies Limited (GET) is a biopharmaceutical company established to develop and commercialise Gene ICE™, a unique and proprietary platform for gene expression regulation. This t...

Collateral Therapeutics Incorporated

Collateral's initial non-surgical gene therapy products under investigation are designed to promote and enhance angiogenesis, a natural biological process which results in the growth of additional blo...

Dimension Therapeutics

Dimension Therapeutics is a gene therapy company focused on developing novel therapies to treat rare diseases. Launched by Fidelity Biosciences in 2013, the Dimension team compris...

Gene Therapy Systems (GTS)

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is ...

Human Genome Sciences Incorporated

Human Genome Sciences, Inc. is engaged in the research and development of novel, proprietary pharmaceutical and diagnostic products based on the discovery and understanding of the medical utility of g...

More Information about "Gene Company Ltd" on BioPortfolio

We have published hundreds of Gene Company Ltd news stories on BioPortfolio along with dozens of Gene Company Ltd Clinical Trials and PubMed Articles about Gene Company Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gene Company Ltd Companies in our database. You can also find out about relevant Gene Company Ltd Drugs and Medications on this site too.

Quick Search


Relevant Topic

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Corporate Database Quicklinks

Searches Linking to this Company Record